The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Gujarat Terce Laboratories Ltd

Gujarat Terce Laboratories Ltd

BSE 524314 · NSE GUJTERC · ISIN INE499G01013 · Group X · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹37.95

+0.88%

BSE close, 28 August 2026

Market cap

₹29.57 cr

0.8 cr shares · Micro cap

Free float

₹17.73 cr

as published

P/E · P/B

14.2× · 3.34×

EPS ₹2.68 · BV ₹11.36

FY25-26 rev / PAT

47.47 / 2.20

₹ cr, as filed

Filings, window

10

4 selected · 40%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹29.00 52-WK HIGH ₹59.78 ₹37.95 29% of range
Against 52-week high-36.5%
Against 52-week low+30.9%
Day change+0.88%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹2.68
Price / earnings14.16×
Price / book3.34×
Book value — derived, price ÷ P/B₹11.36
Return on equity23.56%
Operating margin-0.12%
Net margin-1.98%

Consistency check

P/B ÷ P/E, which must equal ROE
23.59%
ROE as published
23.56%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 9.00 -0.18 -0.23 -0.12% -1.98%
Mar-26 · Q 11.40 0.10 0.13 3.19% 0.89%
FY25-26 47.47 2.20 2.92 7.66% 4.64%

Quarter on quarter

Revenue, quarter on quarter
-21.1%
Net profit, quarter on quarter
-280.0%
Operating margin, quarter on quarter
-331 bps

Disclosure profile 10 filings in the window

0 median 17.0 p75 · 25 sector max 52 10 16th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Change in Directorate2
Board Outcome1
Results1
Selected sub-total4
Procedural
AGM / EGM3
Annual Report1
Compliance Certificate1
Newspaper Publication1
Procedural sub-total6
Total10

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group X, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

10 filings · 4 selected · busiest 2026-08-21

Filing rhythm · the twelve most recent

2026-07-282026-10-09

SelectedProcedural

Filings

10 in the window · 3 earlier on record

  1. 9 October 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Detailed disclosure is attached.

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  2. 21 August 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Detailed disclosure is attached

    AGM/EGM / AGM View filing →

  3. 21 August 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Detailed disclosure is attached.

    AGM/EGM / AGM View filing →

  4. 21 August 2026 ·

    Change in Directorate

    Change in Directorate

    Detailed disclosure is attached.

    Company Update / Change in Directorate View filing →

  5. 21 August 2026 ·

    Change in Directorate

    Change in Directorate

    Corrigendum/Revised intimation regarding Re-appointment of Managing Director & Chief Executive Officer of the Company- Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) ....

    Company Update / Change in Directorate View filing →

  6. 7 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Outcome Of The Board Meeting Held On 7 August 2026

    Detailed disclosure is attached.

    Board Meeting / Outcome of Board Meeting View filing →

  7. 7 August 2026 ·

    Results

    Unaudited Standalone Financial Results Of The Company For The First Quarter Ended 30 June 2026

    Detailed disclosure is attached.

    Result / Financial Results View filing →

  8. 30 July 2026 ·

    Newspaper Publication

    Newspaper Publication

    Detailed disclosure is attached.

    Company Update / Newspaper Publication View filing →

  9. 28 July 2026 ·

    AGM / EGM

    41St AGM Of The Shareholders Of Gujarat Terce Laboratories Limited Will Be Held On 21St August, 2026 At 12:00 Noon.

    41st AGM of the shareholders of Gujarat Terce Laboratories Limited will be held on 21st August, 2026 at 12:00 noon through Video Conferencing or any other Audio-Visual Means facility

    AGM/EGM / AGM View filing →

  10. 28 July 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    Annual Report for FY: 2025-26 is attached.

    Others / Reg. 34 (1) Annual Report View filing →

RSS feed for Gujarat Terce Laboratories Ltd · the 50 most recent filings